Y, K., T, I., N, M., S, N., R, K., Y, H., . . . T, K. (2013). Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: A case report. Dove Medical Press.
Cita Chicago Style (17a ed.)Y, Kitaichi, Inoue T, Mitsui N, Nakagawa S, Kameyama R, Hayashishita Y, Shiga T, Kusumi I, y Koyama T. Selegiline Remarkably Improved Stage 5 Treatment-resistant Major Depressive Disorder: A Case Report. Dove Medical Press, 2013.
Cita MLA (8a ed.)Y, Kitaichi, et al. Selegiline Remarkably Improved Stage 5 Treatment-resistant Major Depressive Disorder: A Case Report. Dove Medical Press, 2013.
Precaución: Estas citas no son 100% exactas.